Valuation
Is the price right?2/2 inputs reported · High confidence
Weaker than most peers on:
- ▼ P/B
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Sep 30, 2026
2/2 inputs reported · High confidence
Weaker than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Why it changed since the Oct 27, 2026 close: Score 34 → 35
Weaker than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Why it changed since the Oct 27, 2026 close: Score 50 → 49
Held back by:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Net income (12 months) | 27.8M USD | 28.7M USD | +3.4% |
| Free cash flow (12 months) | 42.9M USD | 49.1M USD | +14.5% |
| Cash | 79.0M USD | 118.2M USD | +49.6% |
| Shares outstanding | 18.3M | 18.5M | +1.2% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Return on assets (ROA) | 1.1% | 1.0% | 0.7% | 1.0% | 0.9% | ▼ 0.0 pts |
| Return on equity (ROE) | 10.3% | 11.0% | 8.6% | 11.5% | 12.0% | ▲ 0.6 pts |
Price history is added with the daily price update and will appear after the next one.